Open Source Health enters an important stage of development on the Hormone Sensor for Women’s Health
Toronto, Ontario, Canada – January 14, 2014: Open Source Health Inc. (CSE:OSH), (Frankfurt:0OS), a cloud based integrative healthcare platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce the Hormone Sensor development has entered an important phase of component optimization for the diagnostic chip dedicated to at-home hormone level testing from a single drop of blood.
“We are one step closer to dramatically changing the way women manage their health and it is exciting to see the progress.” states Sonya Satveit, Founder and CEO of Open Source Health Inc. “Having successfully verified the capability, we are now focusing on the product design and expect working prototypes by Q2 2015.”
One of the significant trends in healthcare is the shift from laboratory testing to point-of-care testing which offers significant benefits such as convenience, cost reductions, improved decision making and results being immediately uploaded into the electronic health record.
According to Pew Research, 7 in 10 U.S. adults track a health indicator for themselves or a loved one. This Quantifiable-Self Movement is being led by the wearable device market, with clinical home testing devices being the next evolution in health tracking.
At the recent Consumer Electronics Show, CSE 2015, the Consumer Electronics Association provided their outlook for 2015 on wearable technology:
“The wearable device revolution is a key category to watch in the coming years, and especially in 2015. CEA projects overall wearable unit sales will reach 30.9 million units (a 61 percent increase from last year) and generate $5.1 billion in revenue in 2015 (a 133 percent increase). CEA’s wearable’s category encompasses fitness activity bands and other health and fitness devices, as well as smart watches and smart eyewear.”
“The current wearable device market is only the tip of the iceberg as consumers strive to take control of their health,” states Dr. Sergey Babichenko, Head of Sensor Development, Hormone Sensing Project. “We are unlocking one of the most sophisticated systems in the human body that determine and drive women’s health each minute of the day.”
About Open Source Health Inc.:
Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is set to lead the current healthcare revolution by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.
For more information, visit www.opensourcehealth.com
For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933 in North America
International Calling: +01.647.872.9986
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known andunknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.